Search API
COVID-19 convalescent plasma offered reduced benefits against severe illness
August 20, 2021
Third mRNA COVID-19 vaccination coming to many Americans
August 18, 2021
CIS43LS is a neutralizing monoclonal antibody evaluated for malaria protection
August 12, 2021
COVID-19 patients can retain broad, effective, long term disease immunity
August 6, 2021
mRNA COVID-19 vaccination often related to myocarditis, and pericarditis diagnosis
August 5, 2021
Flugen Inc.’s Redeeflu M2SR is a supra-seasonal, live, single-replication, intranasal flu vaccine.
August 2, 2021
Hepatitis outbreaks can be reduced with one dose of single-antigen hepatitis A vaccine
August 1, 2021
COVID-19 vaccine generated antibody levels appear to begin declining at six weeks
July 28, 2021
Most recovered COVID-19 patients mount broad, durable immunity after coronavirus infection
July 26, 2021
Human genetic architecture of coronavirus infections and COVID-19
July 26, 2021
- 1 of 236
- next ›